Mission Street and BGO have appointed Bowmer and Kirkland Ltd to lead construction on Fabrica, a 180,000 sq ft science development in central Oxford—the UK’s largest ground-up science project launching in early 2025. Key details of the appointment Project: Fabrica, a new commercial science building. Developers: Mission Street and BGO. Contractor: Bowmer and Kirkland. Location: Central Oxford. Size: 180,000 sq […]
– Phase 1, Syndex Bio have moved in with 10,301 of fitted lab and office space available for immediate occupation – Phase 2, ‘The Briggs’ our 55,000 sq ft new-build lab and office achieved Practical Completion – Phase 3, our 21,500 sq ft single storey R&D units under construction All within a 5 minute walk […]
The Mission Street team were delighted to co-host Nucleome Therapeutics‘s opening event at Inventa. The event was well attended by the wider Oxford life science and tech ecosystem. Great to see Nucleome Therapeutics settled in and thriving at their new home! We look forward to welcoming other tenants imminently to Inventa with more news coming soon. Watch […]
Tristan Capital Partners’ debt fund has refinanced a £310m prime life science portfolio located across Cambridge and Oxford, Green Street News can reveal. Tristan has issued a senior £180m loan – which has been funded by its TIPS One Debt Fund and a co-investment partner – to sponsor BGO and its joint venture partner Mission […]
Mission Street was honoured to host Sarah Haywood, MD at Advanced Oxford, for the launch of their Green Paper on Growing & Diversifying Equity Investment in Oxfordshire at Inventa . The green paper can be accessed in the research section of the Advanced Oxford’s website https://www.advancedoxford.com/latest-research/
